SUTRO BIOPHARMA INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$9.10
-0.44%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-43.0%
3 months
-63.8%
6 months
-74.4%
1 year
-21.6%
Year to date
-21.4%
52-week range
$7.30 – $40.91
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$150.9M
P/E
-0.8
P/B
-1.5
P/S
3.3
Revenue
$45.7M
Net income
-$180.64M
Diluted EPS
-17.36
Gross margin
100.00%
Net margin
-395.20%
Return on equity
185.30%
Total debt
$10.78M
Cash
$55.19M
Free cash flow
-$145.62M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $9.84M | -$38.53M | 100.00% | -391.60% | -$38.29M |
| Mar 31, 2026 | $14.52M | -$38.48M | 100.00% | -265.00% | -$42.27M |
| Dec 31, 2025 | $11.65M | -$46.76M | 100.00% | -401.50% | -$26.62M |
| Sep 30, 2025 | $9.69M | -$56.86M | 100.00% | -586.60% | -$38.44M |
| Jun 30, 2025 | $63.75M | -$11.5M | 100.00% | -18.00% | -$44.81M |
| Mar 31, 2025 | $17.4M | -$75.97M | 100.00% | -436.60% | -$69.06M |
| Dec 31, 2024 | $14.81M | -$72.44M | 100.00% | -489.20% | -$72.81M |
| Sep 30, 2024 | $8.52M | -$48.79M | 100.00% | -572.60% | -$65.34M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent STRO news
All market newsNo ticker-linked stories are in the current archive.